The Future of Molecular Diagnostics

June 6, 2011 - PRLog -- Bharatbook.com has added this latest report "The Future of Molecular Diagnostics: Innovative technologies driving market opportunities in personalized medicine" to their extensive collection of market research reports. Molecular diagnostics, essentially the analysis of DNA and RNA at the molecular level, is a fast-growing business, made possible by the growing understanding of the human genome, which has spurred growth in the diagnostic business. Given the established importance of DNA in molecular biology and its central role in determining the fundamental operation of cellular processes, molecular diagnostics is making it possible to detect infectious disease and cancer more accurately at an earlier stage than before.

The technology also is optimizing testing for sexually transmitted diseases and genetic testing. Molecular diagnostics is also addressing the need for tests that monitor the therapeutic efficacy of pharmaceuticals. In this way, it has evolved into an important business opportunity for in-vitro diagnostics makers.

Molecular diagnostics is expanding beyond just the identification of infections. It is becoming an integral part of disease management and therapy, finding such applications as patient stratification, drug regimen selection, toxicity avoidance, therapeutic monitoring, and detection of predisposition to disease. Hospitals and diagnostic laboratories using molecular diagnostic techniques need products that guarantee the highest levels of reliability and the greatest speed. Reliability is essential, because an inaccurate or missed diagnosis can be a matter of life and death. Another issue driving the need for new molecular diagnostics involves the ability of microorganisms to evade and even inactivate potent antibiotics, causing health care givers to be faced with substantial infectious disease challenges. The variety of technologies used in molecular diagnostics has transformed clinical laboratory medicine.

Key features of this report

• Explanation of how molecular diagnostics represents a business opportunity for the IVD industry. What is causing this growth – increasing diagnostic efficiency, optimizing treatment with drugs.
• Evaluation of the drivers and trends behind the growth of molecular diagnostics…how the science and technology of molecular diagnostics is becoming more important to clinical labs and drug companies with its increasing sensitivity and new platform technologies.
• Key challenges facing molecular diagnostic manufacturers and those companies looking to enter the market: The need for developing simple to use, automated products; dealing with a complex regulator environment; gaining access to financing and innovation.
• Analysis of markets by key types of testing, products, and by country; analysis showing the top products and opportunities.

Scope of this report

• Understand each market in terms of size as well as its future potential.
• Understand which key products are already in the market place for each market segment analyzed.
• Evaluate in which segment future opportunities may lie for companies.
• Understand some of the key issues and challenges facing molecular diagnostics makers and their component suppliers. Potential entrants into the market can see what types of issues they will be facing.
• Learn about possible products from recent market developments mentioned in the report.

Key Market Issues

• To facilitate routine testing across a wider range of hospitals and reference laboratories, the market is demanding cost effective and simple-to-perform tests that have cleared the many regulatory hurdles. Automation is playing a key role in the development of tests that are easier and less expensive to operate.
• Infectious disease testing represents a large portion of the current market, given the re-emergence of infectious threats, including multidrug-resistant TB, new strains of HIV, and H1N1.
• Many drug companies are investing significantly in pharmacogenomics in anticipation of shaving years off the drug discovery and approval process, bringing potentially lucrative drugs to market much sooner.
• Through 2015, the molecular diagnostics market will grow at a double-digit pace, achieving an overall 14% compound annual growth rate to meet increasing demand for personalized medicine.
• Key areas of growth include infectious diseases, oncology, genetic testing and blood banking. A wide variety of drugs in late preclinical and early clinical development are being targeted to disease-specific gene and protein defects that will require coapproval of diagnostic and therapeutic products by regulatory agencies.

For more information kindly visit: http://www.bharatbook.com/detail.asp?id=144695&rt=The-Fut...                        

Related Reports:
Molecular Diagnostics Bundle Reports
http://www.bharatbook.com/detail.asp?id=192407&rt=Molecul...  

The 2011 Spanish Molecular Diagnostics Market
http://www.bharatbook.com/detail.asp?id=168891&rt=The-201...  

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook
Please visit our blog at http://bharatresearch.wordpress.com

# # #

Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, conferences & seminars, newsletters, and online databases for the past twenty two years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.